GoodRx Holdings (GDRX) reported Q4 adjusted earnings Thursday of $0.09 per diluted share, up from $0.08 a year earlier.
Analysts polled by FactSet expected $0.09.
Revenue for the quarter ended Dec. 31 was $198.6 million, up from $196.6 million a year earlier.
Analysts surveyed by FactSet expected $199.8 million.
The company expects revenue of $201 million to $205 million for Q1 and $810 million to $840 million for 2025. Analysts surveyed by FactSet expect $202.8 million and $825.2 million, respectively.
The company's shares were up 1% in premarket activity Thursday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments